Pseudomvxoma peritonei: A review

Jonathan Carter, L. F. Carson, M. M. Moradi, L. A. Adcock, L. B. Twiggs

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Carter J, Carson LF, Moradi MM, Adcock LA, Twiggs LB. Pseudomyxoma peritonei: a review. Int Gynecol Cancer 1991; 1: 243-247. Pseudomyxoma peritonei is an uncommon clinical entity. It is characterized by massive abdominal distension by gelatinous material. It is produced by mucous-secreting peritoneal implants which are secondary, usually, to an ovarian or appendiceal neoplasm. Although remaining localized to the peritoneal cavity and hence thought to be a benign process, the clinical course of the disease, the association, in the majority of cases, with a malignant primary tumor, and the report of a small number of cases with extraperitoneal spread lends support to the belief that this is a malignant disease. Five-year survival is 68% with ten-year survival at 52%. Despite the utilization of numerous adjuvant therapies, the mainstay of treatment remains complete surgical debulking at initial presentation followed by palliative debulking for symptomatic relief.

Original languageEnglish (US)
Pages (from-to)243-247
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume1
Issue number6
StatePublished - 1991
Externally publishedYes

Fingerprint

Pseudomyxoma Peritonei
Appendiceal Neoplasms
Peritoneal Cavity
Ovarian Neoplasms
Neoplasms
Therapeutics

Keywords

  • Cystadenoma
  • Mucinous
  • Peritonei
  • Pseudomyxoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Carter, J., Carson, L. F., Moradi, M. M., Adcock, L. A., & Twiggs, L. B. (1991). Pseudomvxoma peritonei: A review. International Journal of Gynecological Cancer, 1(6), 243-247.

Pseudomvxoma peritonei : A review. / Carter, Jonathan; Carson, L. F.; Moradi, M. M.; Adcock, L. A.; Twiggs, L. B.

In: International Journal of Gynecological Cancer, Vol. 1, No. 6, 1991, p. 243-247.

Research output: Contribution to journalArticle

Carter, J, Carson, LF, Moradi, MM, Adcock, LA & Twiggs, LB 1991, 'Pseudomvxoma peritonei: A review', International Journal of Gynecological Cancer, vol. 1, no. 6, pp. 243-247.
Carter J, Carson LF, Moradi MM, Adcock LA, Twiggs LB. Pseudomvxoma peritonei: A review. International Journal of Gynecological Cancer. 1991;1(6):243-247.
Carter, Jonathan ; Carson, L. F. ; Moradi, M. M. ; Adcock, L. A. ; Twiggs, L. B. / Pseudomvxoma peritonei : A review. In: International Journal of Gynecological Cancer. 1991 ; Vol. 1, No. 6. pp. 243-247.
@article{94d94882a4634cf5b2a0aa8b505cd9f6,
title = "Pseudomvxoma peritonei: A review",
abstract = "Carter J, Carson LF, Moradi MM, Adcock LA, Twiggs LB. Pseudomyxoma peritonei: a review. Int Gynecol Cancer 1991; 1: 243-247. Pseudomyxoma peritonei is an uncommon clinical entity. It is characterized by massive abdominal distension by gelatinous material. It is produced by mucous-secreting peritoneal implants which are secondary, usually, to an ovarian or appendiceal neoplasm. Although remaining localized to the peritoneal cavity and hence thought to be a benign process, the clinical course of the disease, the association, in the majority of cases, with a malignant primary tumor, and the report of a small number of cases with extraperitoneal spread lends support to the belief that this is a malignant disease. Five-year survival is 68{\%} with ten-year survival at 52{\%}. Despite the utilization of numerous adjuvant therapies, the mainstay of treatment remains complete surgical debulking at initial presentation followed by palliative debulking for symptomatic relief.",
keywords = "Cystadenoma, Mucinous, Peritonei, Pseudomyxoma",
author = "Jonathan Carter and Carson, {L. F.} and Moradi, {M. M.} and Adcock, {L. A.} and Twiggs, {L. B.}",
year = "1991",
language = "English (US)",
volume = "1",
pages = "243--247",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Pseudomvxoma peritonei

T2 - A review

AU - Carter, Jonathan

AU - Carson, L. F.

AU - Moradi, M. M.

AU - Adcock, L. A.

AU - Twiggs, L. B.

PY - 1991

Y1 - 1991

N2 - Carter J, Carson LF, Moradi MM, Adcock LA, Twiggs LB. Pseudomyxoma peritonei: a review. Int Gynecol Cancer 1991; 1: 243-247. Pseudomyxoma peritonei is an uncommon clinical entity. It is characterized by massive abdominal distension by gelatinous material. It is produced by mucous-secreting peritoneal implants which are secondary, usually, to an ovarian or appendiceal neoplasm. Although remaining localized to the peritoneal cavity and hence thought to be a benign process, the clinical course of the disease, the association, in the majority of cases, with a malignant primary tumor, and the report of a small number of cases with extraperitoneal spread lends support to the belief that this is a malignant disease. Five-year survival is 68% with ten-year survival at 52%. Despite the utilization of numerous adjuvant therapies, the mainstay of treatment remains complete surgical debulking at initial presentation followed by palliative debulking for symptomatic relief.

AB - Carter J, Carson LF, Moradi MM, Adcock LA, Twiggs LB. Pseudomyxoma peritonei: a review. Int Gynecol Cancer 1991; 1: 243-247. Pseudomyxoma peritonei is an uncommon clinical entity. It is characterized by massive abdominal distension by gelatinous material. It is produced by mucous-secreting peritoneal implants which are secondary, usually, to an ovarian or appendiceal neoplasm. Although remaining localized to the peritoneal cavity and hence thought to be a benign process, the clinical course of the disease, the association, in the majority of cases, with a malignant primary tumor, and the report of a small number of cases with extraperitoneal spread lends support to the belief that this is a malignant disease. Five-year survival is 68% with ten-year survival at 52%. Despite the utilization of numerous adjuvant therapies, the mainstay of treatment remains complete surgical debulking at initial presentation followed by palliative debulking for symptomatic relief.

KW - Cystadenoma

KW - Mucinous

KW - Peritonei

KW - Pseudomyxoma

UR - http://www.scopus.com/inward/record.url?scp=0003385674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0003385674&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0003385674

VL - 1

SP - 243

EP - 247

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 6

ER -